FDA OKs for Use Noninvasive Stool Sample Test to Help Diagnose IBD
News
Bühlmann Laboratories has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its noninvasive fCAL Elisa test, which uses a stool sample to help diagnose inflammatory bowel disease (IBD). fCAL ... Read more